Advertisement
Screener

PROFUSA, INC. (PFSA) Cash Equivalents, at Carrying Value

2.8 / 5 stars · 68/120 Roast Me

PROFUSA, INC. Cash Equivalents, at Carrying Value

PROFUSA, INC. (PFSA) had Cash Equivalents, at Carrying Value of $194.22 million as of 2022-12-31, per its 10-Q filed 2023-11-20.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:CashEquivalentsAtCarryingValue · last filed 2023-11-20

  • 2022-12-31: Cash Equivalents, at Carrying Value $194.22M.
  • 2022-09-30: Cash Equivalents, at Carrying Value $193.02M.
  • 2022-06-30: Cash Equivalents, at Carrying Value $191.88M.
  • 2022-03-31: Cash Equivalents, at Carrying Value $191.73M.
Period endCash Equivalents, at Carrying Value
2022-12-31$194.22M
10-Q · filed 2023-11-20
2022-09-30$193.02M
10-Q · filed 2022-11-10
2022-06-30$191.88M
10-Q · filed 2022-08-11
2022-03-31$191.73M
10-Q · filed 2022-05-12
2021-12-31$191.65M
10-K · filed 2023-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tenon Medical, Inc. (TNON)United States$0.002B
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
NEXGEL, INC. (NXGL)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B